Business NewsPR NewsWire • NextWave Pharmaceuticals and Tris Pharma Enter into CNS-focused Development and Commercialization Agreement

NextWave Pharmaceuticals and Tris Pharma Enter into CNS-focused Development and Commercialization Agreement

NextWave Pharmaceuticals and Tris Pharma Enter into CNS-focused Development and Commercialization Agreement

CUPERTINO, Calif. and MONMOUTH JUNCTION, N.J., Aug. 12 /PRNewswire/ -- NextWave Pharmaceuticals and Tris Pharma, both privately held companies, announced a new  collaboration agreement to enhance NextWave's CNS product portfolio utilizing Tris Pharma's unique drug delivery technology for liquid

View More : http://www.prnewswire.com/news-releases/nextwave-pharmaceuticals-and-tris-pharma-enter-into-cns-focused-development-and-...
Releted News by prnewswire
International Hydroponics Expert Uses Pioneering New Hydroponics Nutrients to Grow Prize-Winning Medical Marijuana
Prudential - 2010 HY Results Interviews with Group CEO and CFO
UBM TechInsights Confirms that the iPad was Designed to Use a Gyroscope
NextWave Pharmaceuticals and Tris Pharma Enter into CNS-focused Development and Commercialization Agreement
MoMA Launches Free iPhone App on App Store